CB vs PTGX · P/E 14, rev $59.40B vs rev $269.8M
Chubb Ltd (CB) versus Protagonist Therapeutics Inc (PTGX) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
CB currently screens at market cap $114.26B and trailing P/E 13.7. PTGX currently screens at market cap $7.25B.
Not investment advice. Open the CB and PTGX stock pages for the full models.
Not investment advice.